DrugsControl Media Services
DrugsControl.org

News Detail

US FDA Clarifies Results of Recent Advisory Committee, current scientific data do not support effectiveness of phenylephrine as nasal decongestant (15-09-2023)

Maryland, 14 Sept 2023: FDA held a Non-prescription Drug Advisory Committee meeting Sept. 11-12, 2023, to discuss the effectiveness of oral phenylephrine as an active ingredient in over-the-counter (OTC) cough and cold products that are indicated for the temporary re......
View Details

Source : US FDA STATEMENT
Non-prescription Drug Advisory Committee FDA OTC cough and cold products phenylephrine nasal decongestant

Related News